Your session is about to expire
← Back to Search
Affective Awareness for Suicide Prevention (ALEXIS Trial)
ALEXIS Trial Summary
This trial is testing a novel intervention that uses smartphones to reduce suicide risk in Veterans with serious mental illness by targeting their emotion awareness and social functioning.
ALEXIS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ALEXIS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with PTSD.I have been diagnosed with schizophrenia.
- Group 1: Affective Awareness
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What potential risks might accompany Affective Awareness treatment?
"Given the preliminary nature of this clinical trial, Affective Awareness is assigned a safety rating of 1. This score reflects the limited data available to assess its safety and efficacy."
Are there any vacancies remaining in this clinical research endeavor?
"Clinicaltrials.gov confirms that this clinical trial is not actively recruiting participants at the moment, with an original posting on April 1st 2023 and a last update occurring on February 13th of the same year. Notwithstanding, there are 2377 other trials currently searching for patient volunteers."
Share this study with friends
Copy Link
Messenger